<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ro">
	<id>https://wiki.tradeville.ro/index.php?action=history&amp;feed=atom&amp;title=PDS_Biotechnology_Corporation</id>
	<title>PDS Biotechnology Corporation - Revizia istoricului</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.tradeville.ro/index.php?action=history&amp;feed=atom&amp;title=PDS_Biotechnology_Corporation"/>
	<link rel="alternate" type="text/html" href="https://wiki.tradeville.ro/index.php?title=PDS_Biotechnology_Corporation&amp;action=history"/>
	<updated>2026-04-06T21:41:09Z</updated>
	<subtitle>Istoricul versiunilor pentru această pagină din wiki</subtitle>
	<generator>MediaWiki 1.39.2</generator>
	<entry>
		<id>https://wiki.tradeville.ro/index.php?title=PDS_Biotechnology_Corporation&amp;diff=435341&amp;oldid=prev</id>
		<title>Admin: Pagină nouă: Pagina dedicata companiei PDS Biotechnology Corporation listata cu simbolul US.PDSB  ==Descriere companie== PDS Biotechnology Corporation (https://www.pdsbiotech.com) is a clinical-stage immunotherapy company. The Company is focused on developing a growing pipeline of cancer immunotherapy candidates and infectious disease vaccine candidates designed to overcome the limitations of immunotherapy technologies. It owns Versamune, a T-cell activating platform designed to train the...</title>
		<link rel="alternate" type="text/html" href="https://wiki.tradeville.ro/index.php?title=PDS_Biotechnology_Corporation&amp;diff=435341&amp;oldid=prev"/>
		<updated>2024-09-18T18:20:45Z</updated>

		<summary type="html">&lt;p&gt;Pagină nouă: Pagina dedicata companiei PDS Biotechnology Corporation listata cu simbolul US.PDSB  ==Descriere companie== PDS Biotechnology Corporation (https://www.pdsbiotech.com) is a clinical-stage immunotherapy company. The Company is focused on developing a growing pipeline of cancer immunotherapy candidates and infectious disease vaccine candidates designed to overcome the limitations of immunotherapy technologies. It owns Versamune, a T-cell activating platform designed to train the...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Pagină nouă&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Pagina dedicata companiei PDS Biotechnology Corporation listata cu simbolul US.PDSB&lt;br /&gt;
&lt;br /&gt;
==Descriere companie==&lt;br /&gt;
PDS Biotechnology Corporation (https://www.pdsbiotech.com) is a clinical-stage immunotherapy company. The Company is focused on developing a growing pipeline of cancer immunotherapy candidates and infectious disease vaccine candidates designed to overcome the limitations of immunotherapy technologies. It owns Versamune, a T-cell activating platform designed to train the immune system to destroy disease. Its lead product candidate, PDS0101, which combines Versamune with a mixture of short proteins (peptides) derived from the cancer-causing HPV16 viral protein. Its pipeline also includes PDS0102, PDS0103 and PDS0104. Its pipeline of Versamune-based products is all administered by subcutaneous injection. DS0102 is being developed for the treatment of prostate and breast cancers. PDS0103 is based on agonist antigens from the mucin-1 (MUC-1) oncogenic C-terminal region. PDS0104 is being developed for the treatment of melanoma.&lt;br /&gt;
&lt;br /&gt;
==Grafic actiuni companie==&lt;br /&gt;
&amp;lt;iframe key=&amp;quot;tradeville&amp;quot; path=&amp;quot;graficSimbol/US.PDSB&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Ultimele stiri despre PDS Biotechnology Corporation (US.PDSB)==&lt;br /&gt;
&amp;lt;dynamicpagelist&amp;gt;&lt;br /&gt;
category=US.PDSB&lt;br /&gt;
count=10&lt;br /&gt;
order=descending&lt;br /&gt;
addfirstcategorydate=false&lt;br /&gt;
&amp;lt;/dynamicpagelist&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Categorie:US.PDSB]][[Categorie:Stiri despre companii]]&lt;/div&gt;</summary>
		<author><name>Admin</name></author>
	</entry>
</feed>